UBS lowered the firm’s price target on Gartner to $510 from $550. While Q1 CV was disappointing, UBS keeps a Buy rating on the shares as as the firm expects CV growth to re-accelerate in Q2 and Q3 and its conviction in margin upside increases with the Q1 beat and raise, the analyst tells investors in a research note.